X

Trial Profile

Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism in Europe - ETNA-VTE-Europe

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 19 Feb 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Edoxaban (Primary)
Indications Venous thromboembolism
Focus Adverse reactions
Acronyms ETNA-VTE; ETNA-VTE-Europe
Sponsors Daiichi Sankyo Europe; Daiichi Sankyo Inc

Most Recent Events

09 Apr 2021 Status changed from active, no longer recruiting to completed.
14 Jul 2020 According to a Daiichi Sankyo media release results from this trial were presented during the International Society on Thrombosis and Haemostasis (ISTH) 2020 Virtual Congress.
14 Jul 2020 Results published in the Media Release

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com